This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
SureNano Science highlighted in BioMedWire editorial for next-gen GLP-1 innovation. Subsidiary GlucaPharm developing GEP-44 peptide for obesity and metabolic disease with improved tolerability. #GLP1 #Biotech
2026-05-15T02:53:25.274Z